Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Scalp cooling effectively reduces hair loss in breast cancer patients undergoing chemotherapy.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Minoxidil improves hair loss in breast cancer patients on CDK4/6-inhibitor therapy.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Fucoidan may help treat lung cancer by altering gene expression in cancer cells.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Different types of persistent hair loss after chemotherapy respond differently to treatments.